Jie Jiang
Affiliations: | 2012-2016 | School of Life Sciences, Xiamen University |
Google:
"Jie Jiang"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Xianming DENG | grad student | 2012-2016 | School of Life Sciences, Xiamen University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhao H, Beyett TS, Jiang J, et al. (2024) Biochemical analysis of EGFR exon20 insertion variants insASV and insSVD and their inhibitor sensitivity. Proceedings of the National Academy of Sciences of the United States of America. 121: e2417144121 |
| Jiang J, Yang L, Xie Q, et al. (2024) Synthetic vectors for activating the driving axis of ferroptosis. Nature Communications. 15: 7923 |
| Gui F, Jiang B, Jiang J, et al. (2024) Acute BRCAness Induction and AR Signaling Blockage through CDK12/7/9 Degradation Enhances PARP Inhibitor Sensitivity in Prostate Cancer. Biorxiv : the Preprint Server For Biology |
| Ji W, Du G, Jiang J, et al. (2024) Discovery of bivalent small molecule degraders of cyclin-dependent kinase 7 (CDK7). European Journal of Medicinal Chemistry. 276: 116613 |
| Li Z, Jiang J, Ficarro SB, et al. (2024) Molecular Bidents with Two Electrophilic Warheads as a New Pharmacological Modality. Acs Central Science. 10: 1156-1166 |
| Li Z, Lu W, Beyett TS, et al. (2024) ZNL0325, a Pyrazolopyrimidine-Based Covalent Probe, Demonstrates an Alternative Binding Mode for Kinases. Journal of Medicinal Chemistry |
| Li Y, Jiang J, Wang X, et al. (2023) Engrailed 2 serves as a master regulator of the super-enhancer in the TNC gene locus in non-small cell lung cancer. Environmental Toxicology |
| Zhao S, Li Y, Li G, et al. (2023) PI3K/mTOR inhibitor VS-5584 combined with PLK1 inhibitor exhibits synergistic anti-cancer effects on non-small cell lung cancer. European Journal of Pharmacology. 176004 |
| Liu Y, Guo Z, Lang F, et al. (2023) Anticancer Effect of Active Component of Astragalus Membranaceus Combined with Olaparib on Ovarian Cancer Predicted by Network-Based Pharmacology. Applied Biochemistry and Biotechnology |
| Teng M, Jiang J, Wang ES, et al. (2023) Targeting the Dark Lipid Kinase PIP4K2C with a Potent and Selective Binder and Degrader. Angewandte Chemie (International Ed. in English). e202302364 |